chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Secod dose 12 days later than the original scheduled date; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Secod dose 12 days later than the original scheduled date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Secod dose 12 days later than the original scheduled date). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Secod dose 12 days later than the original scheduled date) had resolved.            The patient missed their scheduled second dose (was supposed to be 17-Mar-2021) and was instead going to receive their second dose on 29-Mar-2021.  Action taken with mRNA-1273 in response to the event was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.
9-13-2021 COVID SHOT S/S-LEFT ARM EXTREMELY SORE , LEFT AXILLA LYMPH NODULE, TO LEFT BREAST HARD-SWOLLEN 10-11-2021 102 DEGREE FEVER, LEFT ARM ERYTHEMA DURATION SIZE 3-4 INCHES X 3-4 INCHES, EXTREME  BODY ACHES, HEADACHE, NAUSEA.   WILL NEVER GET THIS SHOT AGAIN AND WILL LEAVE NURSING IF EVER REQUIRED TO GET THE BOOSTER
Itching and mild errythema around injection site within 5 minn of administration.  No other problems.  Given 1 tsp Benadryl and observed x30 minn.  Itching and redness resolved.
I experienced a breakthrough case of COVID-19 with sore throat, cough and congestion.
Initial report received from a healthcare professional on 17 October 2013. A 76-year-old patient, whose gender, medical history and concomitant medication was not reported had received a second dose FLUZONE HD (batch number: U4762BA, route of administration were not reported) in left deltoid on 08 October 2012.  On 06 October 2012, the patient complaint that, redness, firmness around site, star burst pattern, itchy bumps (blisters that broke open and scabbed), 3".  The patient corrective treatments and laboratory investigations were not reported. On an unspecified date, the patient was recovered from the event.  Documents held by sender: none
Evening 4/12 after multiple vaccines was very fussy, crying and possibly "turned blue" on his face - no hx. of apnea. Rx with TYLENOL then did well.
Received vaccine's on 10/14/2003, mother called on 10/16/2003 stating that on the morning of 10/15/2003 child's left leg was "shaking" which prevented him from walking for 1 1/2 day's, and he limped for a total of 5 days.
History of noisy breathing (stridor) and difficulty breathing 5-6 hrs after receiving DTaP.  Also hx of shaking episode at same time.
Pt. given 2nd dose of meningococcol (Menactra) in error.  First dose given at M.D. office 04/16/2008.  Nurse did not adequately check vaccine history document to notice vaccine already given. No adverse reaction to report at this time. Mother of patient notified of error.
Heart Attack, burning from center of chest expanding to back like a dagger and outwards 1 stent placed to stop it 2 more stents the next day preventative Now attending cardiac rehab New meds prescribed
Given  covid vacc from vial that was expired by a couple of hours. (vial was refrigerated the whole time). NO adverse effect reported.
(2nd dose not received yet) outside of recommended time frame; chills; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE ((2nd dose not received yet) outside of recommended time frame), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE ((2nd dose not received yet) outside of recommended time frame), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, PRODUCT DOSE OMISSION ISSUE ((2nd dose not received yet) outside of recommended time frame), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported. No treatment medications was reported.
Arm pain one week after vaccine; vaccination site is hot and tender to the touch; experienced itchiness; resulting in arm pain extending from shoulder to forearm and arm weakness
Patient found to be anemic on 9/21/22 duriing routine blood work.  Further screening deteremined that he had Invasive Adenocarcinoma of the colon, Stage II.  Colon resection on 1/31/2023.
fever of 105 starting on 12/7/19, hives several days later; headache, fatigue
1) After at 6-8 hours (for both 1st & 2nd dose) fever, chills, headache, cough, extreme weakness & dizziness 2) on routine memogram (3/11/21) abnormality found. Detailed memogram (3/23/21) abnormal. Biopsy (3/25/21) normal metal chip insertion left breast 2 weeks of extreme mental stress, left full time job which was just joined in different city.
Fall of 2003 began gaining weight,some depression. Jan04 abdominal pain and diarrhea. Tx with Cipro and Metronidazole diarrhea continued colonoscopy found inflammation. Tx with Cortizone enemas q day. Weight gain continued, swelling decreased extra.
Patient tested positive for covid on 12/24/2021. Patient also has lost 20lbs in last 3 months and now has a newly diagnosed esophageal cancer
About 5 minutes, post vax, the pt experienced a metallic taste in her mouth, which lasted about 1/2 hour and resolved. The pt recovered from this experience. From additional information received on 12/15/1998, it was reported, "reviewed, no additional information at this time; 12/12/98.
Shortness of breath requiring use of non-prescription and prescription medication. Symptoms improved after treatment with diphenhydramine and albuterol and patient left clinic after 35 minute observation.
Received Moderna booster?Back of tongue began to hurt near throat, Gums in mouth swelled up and could not go without ice/cold in my mouth at all times excruciating pressure pain
4 HOURS AFTER VACCINATION--LARGE WELTS ON FACE. WELTS WERE HOT AND PAINFUL. PATIENT TREATED WITH BENADRYL ORALLY AND ICE PACKS. REACTION RESOLVED BY NEXT MORNING
Pt received the dose for 12 and up of pfizer -BioNtech Covid 19 Bivalent instead of receiving the child dose of 5-11 y/o.
(L) arm where DTAP/IPV administration has a 2 cm oval redness tender. Placed on AUGMENTIN/warm compress.
having a reaction; gave it to her subcutaneously; This case was reported by a pharmacist via interactive digital media and described the occurrence of adverse reaction in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced adverse reaction and intramuscular formulation administered by other route. On an unknown date, the outcome of the adverse reaction and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient received her Shingrix shot from her physician but was having a reaction. By talking to the patient the reporter realized that they gave it to the patient subcutaneously instead in deltoid, which led to intramuscular formulation administered by other route.
Aches; Chills; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), MYALGIA (Aches) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 31-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jan-2021, the patient experienced DIZZINESS (Dizzy). On an unknown date, the patient experienced MYALGIA (Aches) and CHILLS (Chills). At the time of the report, DIZZINESS (Dizzy), MYALGIA (Aches) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
headache; sore arm; Loss apetite; body ache; nausea; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), DECREASED APPETITE (Loss apetite), HEADACHE (headache), MYALGIA (body ache) and NAUSEA (nausea) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma since 1950. Concomitant products included ALBUTEROL SULFATE from 01-Jan-2020 to an unknown date for Wheezing.    On 18-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced DECREASED APPETITE (Loss apetite), MYALGIA (body ache), NAUSEA (nausea), PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). On 19-Feb-2021, DECREASED APPETITE (Loss apetite), MYALGIA (body ache), NAUSEA (nausea), PYREXIA (Fever) and CHILLS (Chills) had resolved with sequelae. At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-054508 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Reporters address added. Patients race and ethnicity added. Current condition added. Concomitant drug added. Outcome updated to recovered/resolved with residual effects. Causality of events updated.
HCP calling to report AE for Supported TE for VARIVAX.; This spontaneous report was received from a Registered Nurse and refers to a 15-month-old patient of unspecified gender.  The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported.  On 03-OCT-2023, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (involved lot # was X007373, expiration date: 12-MAR-2025 [verified to be valid]); single dose, administered for prophylaxis (strength, and route of administration were not provided). Temperature excursion was -14 degree Celsius (°C) to -10°C (-13.0 C) and time frame was for 0 hours 18 minutes. There was a previous temperature excursion of -14°C to -10°C (-13.8 C) for 0 hours 26 minutes.   This is one of five reports from the same reporter.; Sender's Comments:  US-009507513-2310USA001220: US-009507513-2310USA001274:Case # 02485000 US-009507513-2310USA001416:Case # 02485005 US-009507513-2310USA001527:Case # 02485007
Patient states the vaccine was given high on arm and injection site has been extremely sore/painful. Patient also reports loss of mobility. No other symptoms (such as swelling, redness) were reported.
24 hours after injection of either DTaP or IPV, right thigh site became swollen, red, and hot. Slightly tender. Area 3.5cm X 3.5cm in diameter. Treatment with Benadryl PO TID until swelling resolved.
Resident woke up flushed appearing, he had the chills, pale looking. His gait was unsteady, lethargic,  confusion, and complaints of shortness of breath.
I received the first COVID19 vaccine on 1/6/21. One week later (1/13/21)  I developed redness, slight swelling, and slight itchiness at the injection site. I didn't have any other symptoms. The rash slowly resolved over the next 2 days.
Respiratory Distress (cough, low SPO2) and Weakness - Generalized (Fall and was on floor for 16 hours this morning; EMS called and patient refused any treatment )     HISTORY OF PRESENT ILLNESS     Patient presents is an 83-year-old male per private auto for shortness of breath and weakness.   Patient presents per private auto with progression of weakness or last couple of days including increased shortness of breath.  According to family members the patient is experiencing some mild cough and cold symptoms.  Apparently the EMS for called presented to his place earlier today after the patient been found on the floor and apparently been on the floor for approximately over half a day.  Patient refused EMS transport. Respiratory Distress (cough, low SPO2) and Weakness - Generalized (Fall and was on floor for 16 hours this morning; EMS called and patient refused any treatment )     HISTORY OF PRESENT ILLNESS     Patient presents is an 83-year-old male per private auto for shortness of breath and weakness. Patient presents per private auto with progression of weakness or last couple of days including increased shortness of breath.  According to family members the patient is experiencing some mild cough and cold symptoms.  Apparently the EMS for called presented to his place earlier today after the patient been found on the floor and apparently been on the floor for approximately over half a day.  Patient refused EMS transport.  However as the day progressed family members were able to get hold his primary care provider who came and did a house call and found it to be quite short of breath, lethargic, extremely weak prompting emergency room visit.   Patient denies any known contacts with persons of COVID-19.  He is vaccinated.  Patient denies any chest pains, palpitations.  Patient is a full code.
rash spots all over body/ appears during night time and disappears during day time; achy; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy) and RASH (rash spots all over body/ appears during night time and disappears during day time) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced MYALGIA (achy). On 27-Apr-2021, the patient experienced RASH (rash spots all over body/ appears during night time and disappears during day time). On 23-Apr-2021, MYALGIA (achy) had resolved. At the time of the report, RASH (rash spots all over body/ appears during night time and disappears during day time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant product included OMEGA 3 OIL for an unknown indication Treatment included BENADRYL and OTC PREDNISONE
Got the jab then had shingles / received the vaccine, then had shingles/Suspected vaccination failure; Horrible shingles, died while battling a horrible bout of shingles / suffered from shingles then passed away; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria death and GSK medically significant) and shingles (serious criteria death). On an unknown date, the outcome of the vaccination failure and shingles were fatal. The reported cause of death was shingles and vaccination failure.   The reporter considered the vaccination failure and shingles to be possibly related to Shingrix.     Additional Information: GSK Receipt Date: 18-SEP-2022 Reporter's comment: This case was reported by a patient via interactive digital media.  The patient had a very health friend and never got shingles. The patient got the jab of shingles then suffered horrible shingles for years then passed away. The patient was died while battling horrible bout of shingles. The reporter stated that, the vaccine could lead to you getting shingles. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.; Reported Cause(s) of Death: Shingles; Vaccination failure
Developed hives all over body 2 days following 2nd dose of Pfizer.
swelling @ site inj upper arm w/erythemic surrounding macules & plaques 1 to 2 cm tender afeb;
Sore arm pain level 6-7 out of 10. Unable to move freely.  fever with temperature 100F, fatigue and sleepy, bad appetite.
Severe nausea, vomiting, dizziness - at the time I did not think about it being related to vaccine - only several years later when it always happened in October did someone say it was probably linked to vaccine.
Within 24 hours , headaches nausea, muscle and joint pain. Approximately 24 hours facial rash/hives , itching and puffiness. Within 48 hours rash spread to neck and chest , day 3 rash/ hives continued, headache and body aches improved, urgent care visit  started on Mederol pack with dx of allergy to COVID vaccine. With steroid dosing facial rash some improvement. Occasional headache no unusual body or joint discomfort above baseline
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of covid-19, drug ineffective.  Clinical course: The patient did not receive other medication in 2weeks. Paxlovid Treatment start date: 19Jul2022 and stop date: 23Jul2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
One week after the first shot I got a raised red ban on my left arm. My doctor saw me in person and said it was COVID arm and that some people were getting it and it would probably go away. By April 2021 (and after my second shot) I began having pain in my upper left arm which felt like burning and pressure.  I was on Sabbatical and traveling but my doctor by phone said to use Tylenol. By the time I got back at the end of July 2021 it was still bothering me and we talked about it at my annual visit. He said to try applying Diclofenac Sodium Topical Gel which provided some relief. By the fall it continued and I called the urgent care. The nurse on call was worried that left arm pain might indicate a heart issue and sent me to the urgent care. That doctor ordered some blood tests and an EKG. I was sure that it was from the shots. The Urgent Care doctor prescribed Cymbalta for the pain which is turns out I had an adverse reaction to and which trigged two emergency room visits, once more with the doctors worrying about cardiac issues. All those test came back fine...and I told them all along the arm pain was from the vaccinations.
Chest tightness, cough, nasal congestion, neck pain & chest pain that continues today yet & Tachycardia
Day of 1st injection I developed crippling headaches. The next day I started having muscle pain, joint pain, headaches continued. In the days that followed I developed a rash that I eventually determined to be from essential oils in a cleansing pad I have been using for years. All symptoms subsided after the 2nd dose. Headaches continue to this day briefly but more overtly is the sensitivity/allergy to essential oils, specifically tea tree oil. I have continued to have hive/rash outbreaks wherever I use tea tree oil, an oil I have been using regularly and with no issue for years. I was prescribed and used clobetasol propionate .05% to treat the hives/rash and it helped.
Information has been received from a registered nurse concerning an 18 year old female patient with seafood allergy, sulfa allergy and ibuprofen allergy who on 24-AUG-2009 was vaccinated IM with the first dose of 0.5 ml GARDASIL (lot # 663451/0216Y). Concomitant therapy included LOESTRIN 24 FE. When the patient saw the doctor on 22-DEC-2009 she said that she experienced hives after the injection. No time frame was offered. On an unknown date, the patient recovered from hives. Additional information has been requested.
Woke up to severe muscle spasms, swollen tongue, swollen neck, resting heartbeat over 150bmp. Could barely walk or talk due to shaking and chills. This lasted 45 minutes but was nearly gone by the time I reached the ER. Doctors gave me a IV with Pepcid, Benadryl and steroids.